An ancillary biomarker study in the SAMIT randomized trial: Sequential paclitaxel followed by UFT or S-1 versus UFT or S-1 alone as adjuvant chemotherapy for T4a/b gastric cancer

Takashi Oshima; Akira Tsuburaya; Kazuhiro Yoshida; Takaki Yoshikawa; Yohei Miyagi; Jia Guan; Patrick Tan; Junichi Sakamoto; Shiro Tanaka

doi:10.4993/acrt.26.39

Annals of Cancer Research and Therapy

Online ISSN : 1880-5469
Print ISSN : 1344-6835
ISSN-L : 1344-6835

An ancillary biomarker study in the SAMIT randomized trial: Sequential paclitaxel followed by UFT or S-1 versus UFT or S-1 alone as adjuvant chemotherapy for T4a/b gastric cancer

Takashi Oshima, Akira Tsuburaya, Kazuhiro Yoshida, Takaki Yoshikawa, Yohei Miyagi, Jia Guan, Patrick Tan, Junichi Sakamoto, Shiro Tanaka

Author information

Keywords: Gastric cancer, Adjuvant chemotherapy, UFT, S-1, Paclitaxel, Predictive biomarker

JOURNAL FREE ACCESS

2018 Volume 26 Issue 1 Pages 39-42

DOI https://doi.org/10.4993/acrt.26.39

Details

Article 1st page

Content from these authors

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!